Shares of Medtronic (MDT), the Dublin-based medical device company, haven't exactly impressed with their 2024 price action. The company's latest results for the fiscal fourth quarter didn't help matters, either; despite beating top and bottom-line estimates, soft earnings guidance for the quarter and year ahead spooked investors, and led to a 5% single-day selloff in the stock post-earnings.
Overall, MDT stock is down 1% on a YTD basis, and the shares are more or less flat over the past year - underperforming the S&P 500 Index ($SPX) considerably.
